An off-the-shelf small extracellular vesicle nanomedicine for tumor targeting therapy

Liang Gong,Lu Tian,Kaisa Cui,Ying Chen,Bingxin Liu,Dan Li,Yuyang Feng,Surui Yao,Yuan Yin,Zhimeng Wu,Zhaohui Huang

DOI: https://doi.org/10.1016/j.jconrel.2023.11.013

IF: 11.467

2023-12-01

Journal of Controlled Release

Abstract:Small extracellular vesicles (sEVs) have shown excellent prospects as drug delivery systems for cancer therapy. However, the inherent non-targeting and short blood circulation characteristics severely restrict their practical applications as a delivery system. In addition, post-encapsulating drugs into sEVs also remains challenging. Here, we constructed an engineered cell line that secreted multifunctional sEVs (termed NBsEV204) with 7D12 (an anti-EGFR nanobody) and hCD47 decorations on their surface, as well as high levels of miR-204-5p encapsulation. NBsEV204 exhibited extended blood circulation and improved macrophage-mediated phagocytosis of tumor cells by blocking CD47 signaling. Importantly, NBsEV204 specifically targeted EGFR⁺ tumor cells and showed robust tumor-suppressive effects both in vitro and in vivo. Overall, this study provides a convenient and feasible method to produce off-the-shelf anticancer sEV nanomedicine, which exhibits tremendous potential for clinical translation.

pharmacology & pharmacy,chemistry, multidisciplinary